Literature DB >> 24605215

Vitamin D and chronic kidney disease-mineral bone disease (CKD-MBD).

Sagar U Nigwekar1, Hector Tamez2, Ravi I Thadhani1.   

Abstract

Chronic kidney disease (CKD) is a modern day epidemic and has significant morbidity and mortality implications. Mineral and bone disorders are common in CKD and are now collectively referred to as CKD- mineral and bone disorder (MBD). These abnormalities begin to appear even in early stages of CKD and contribute to the pathogenesis of renal osteodystrophy. Alteration in vitamin D metabolism is one of the key features of CKD-MBD that has major clinical and research implications. This review focuses on biology, epidemiology and management aspects of these alterations in vitamin D metabolism as they relate to skeletal aspects of CKD-MBD in adult humans.

Entities:  

Year:  2014        PMID: 24605215      PMCID: PMC3944129          DOI: 10.1038/bonekey.2013.232

Source DB:  PubMed          Journal:  Bonekey Rep        ISSN: 2047-6396


  79 in total

1.  Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts.

Authors:  Ron T Gansevoort; Kunihiro Matsushita; Marije van der Velde; Brad C Astor; Mark Woodward; Andrew S Levey; Paul E de Jong; Josef Coresh
Journal:  Kidney Int       Date:  2011-02-02       Impact factor: 10.612

2.  Decreased serum concentrations of 1,25(OH)2-vitamin D3 in patients with gout.

Authors:  S Takahashi; T Yamamoto; Y Moriwaki; Z Tsutsumi; J Yamakita; K Higashino
Journal:  Metabolism       Date:  1998-03       Impact factor: 8.694

Review 3.  The free hormone hypothesis: a physiologically based mathematical model.

Authors:  C M Mendel
Journal:  Endocr Rev       Date:  1989-08       Impact factor: 19.871

4.  Bone mineral density evaluated by dual-energy X-ray absorptiometry after one-year treatment with calcitriol started in the predialysis phase of chronic renal failure.

Authors:  J Przedlacki; J Manelius; K Huttunen
Journal:  Nephron       Date:  1995       Impact factor: 2.847

5.  An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3.

Authors:  A Nykjaer; D Dragun; D Walther; H Vorum; C Jacobsen; J Herz; F Melsen; E I Christensen; T E Willnow
Journal:  Cell       Date:  1999-02-19       Impact factor: 41.582

6.  Increased risk of hip fracture among patients with end-stage renal disease.

Authors:  A M Alem; D J Sherrard; D L Gillen; N S Weiss; S A Beresford; S R Heckbert; C Wong; C Stehman-Breen
Journal:  Kidney Int       Date:  2000-07       Impact factor: 10.612

7.  Relationship between moderate to severe kidney disease and hip fracture in the United States.

Authors:  Thomas L Nickolas; Donald J McMahon; Elizabeth Shane
Journal:  J Am Soc Nephrol       Date:  2006-09-27       Impact factor: 10.121

8.  Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4.

Authors:  Jack W Coburn; Hla M Maung; Logan Elangovan; Michael J Germain; Jill S Lindberg; Stuart M Sprague; Mark E Williams; Charles W Bishop
Journal:  Am J Kidney Dis       Date:  2004-05       Impact factor: 8.860

9.  19-Nor-1-alpha-25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis.

Authors:  K J Martin; E A González; M Gellens; L L Hamm; H Abboud; J Lindberg
Journal:  J Am Soc Nephrol       Date:  1998-08       Impact factor: 10.121

10.  Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure.

Authors:  N A Hamdy; J A Kanis; M N Beneton; C B Brown; J R Juttmann; J G Jordans; S Josse; A Meyrier; R L Lins; I T Fairey
Journal:  BMJ       Date:  1995-02-11
View more
  22 in total

Review 1.  New developments in our understanding of vitamin metabolism, action and treatment.

Authors:  Sylvia Christakos; Shanshan Li; Jessica De La Cruz; Daniel D Bikle
Journal:  Metabolism       Date:  2019-06-19       Impact factor: 8.694

2.  The impact of fish oil and wheat germ oil combination on mineral-bone and inflammatory markers in maintenance hemodialysis patients: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Hadeer Zakaria; Tarek M Mostafa; Gamal A El-Azab; Ahmed M Abd El Wahab; Heba Elshahawy; Nagy Ah Sayed-Ahmed
Journal:  Int Urol Nephrol       Date:  2017-06-30       Impact factor: 2.370

Review 3.  Chronic kidney disease and vitamin D metabolism in human bone marrow-derived MSCs.

Authors:  Shuanhu Zhou; Julie Glowacki
Journal:  Ann N Y Acad Sci       Date:  2017-08       Impact factor: 5.691

Review 4.  Calciphylaxis: risk factors, diagnosis, and treatment.

Authors:  Sagar U Nigwekar; Daniela Kroshinsky; Rosalynn M Nazarian; Jeremy Goverman; Rajeev Malhotra; Vicki Ann Jackson; Mihir M Kamdar; David J R Steele; Ravi I Thadhani
Journal:  Am J Kidney Dis       Date:  2015-05-07       Impact factor: 8.860

Review 5.  Mutations in the vitamin D receptor and hereditary vitamin D-resistant rickets.

Authors:  David Feldman; Peter J Malloy
Journal:  Bonekey Rep       Date:  2014-03-05

Review 6.  Current evidence on vitamin D deficiency and kidney transplant: What's new?

Authors:  Gerardo Sarno; Riccardo Nappi; Barbara Altieri; Giacomo Tirabassi; Emanuele Muscogiuri; Gianmaria Salvio; Stavroula A Paschou; Aristide Ferrara; Enrico Russo; Daniela Vicedomini; Cerbone Vincenzo; Andromachi Vryonidou; Silvia Della Casa; Giancarlo Balercia; Francesco Orio; Paride De Rosa
Journal:  Rev Endocr Metab Disord       Date:  2017-09       Impact factor: 6.514

7.  Biochemical markers of mineral bone disorder in South African patients on maintenance haemodialysis.

Authors:  Bala Waziri; Raquel Duarte; Saraladevi Naicker
Journal:  Afr Health Sci       Date:  2017-06       Impact factor: 0.927

Review 8.  Active Vitamin D in Chronic Kidney Disease: Getting Right Back Where We Started from?

Authors:  Lavinia Negrea
Journal:  Kidney Dis (Basel)       Date:  2018-12-19

Review 9.  The Use of Vitamin D Metabolites and Analogues in the Treatment of Chronic Kidney Disease.

Authors:  Ladan Zand; Rajiv Kumar
Journal:  Endocrinol Metab Clin North Am       Date:  2017-09-29       Impact factor: 4.741

Review 10.  Maintenance of Skeletal Muscle to Counteract Sarcopenia in Patients with Advanced Chronic Kidney Disease and Especially Those Undergoing Hemodialysis.

Authors:  Katsuhito Mori
Journal:  Nutrients       Date:  2021-05-02       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.